U.S.: Bayer Settles Roundup Cancer Lawsuits for Up to $10.9 Billion

By Reuters|24 June 2020

Bayer AG has agreed to pay as much as $10.9 billion to settle thousands of U.S. lawsuits claiming that its widely-used weedkiller Roundup caused cancer after more than a year of talks, resolving litigation that has pummeled the company’s share price.

The German drugs and pesticides maker has come to terms with about 75% of the 125,000 filed and unfiled claims overall, it said in a statement on Wednesday of the deal to end legal disputes it inherited with its $63 billion takeover of Monsanto in 2018.

Advertisement

The settled cases over Roundup and other glyphosate-based weedkillers account for about 95% of those currently set for trial, it added.

Continue reading at Reuters.

Top Articles
Regenerative Ag Shift in Ukraine: How a Climate Fintech Startup Is Leading Restoration of 300,000 Hectares

Reuters brings you the latest news from around the world, covering breaking news in markets, business, politics, technology, and more. See all author stories here.

Hide picture